Como conclusin y ejemplo de la importancia que tienen para el paciente y el onclogo estas lesiones, son interesantes los resultados del estudio de Boone at al89, en el que se interrog a 110 profesionales habituados a usar inhibidores de EGFR (onclogos, enfermeras y farmacuticos) sobre la toxicidad cutnea asociada a los inhibidores de EGFR
Growth factor regulation: BPC-157 has been shown to influence multiple growth factors involved in tissue repair, including EGF (epidermal growth factor), FGF (fibroblast growth factor), and TGF-beta (transforming growth factor-beta) (5)
At Better Med Spa, we never use research-grade peptides
Pre-Blend Dose Assessment (10 units / 0.10 mL daily) Component GHK-Cu Per-dose from Blend ~1.67 mg Typical Standalone 1-2 mg daily Assessment In range Component BPC-157 Per-dose from Blend ~0.33 mg Typical Standalone 0.25-0.5 mg daily Assessment In range Component TB-500 Per-dose from Blend ~0.33 mg Typical Standalone 2-5 mg per injection, 2x/week Assessment Below standalone injury range The 5:1:1 blend is convenience- and skin-focused
Conditions including acute hepatitis, cirrhosis, non-alcoholic fatty liver disease (NAFLD), and liver cancer have all been associated with elevated serum B12
Others experience gradual improvement over one to two weeks